Disabling a standout gene that normally limits guide RNA output increased functional cargo and boosted particle potency across multiple gene-editing platforms and designs.

In the screen, nearly every human gene was knocked out, and the resulting disruptions were tracked in the produced particles to determine impact on production.

A negative regulator of particle production was identified; its knockout raised guide RNA output and yielded more potent VLP cargo across tools and designs.

Some gene knockouts increased production of particle components but reduced delivery potency, showing context-dependent effects and the need to balance pathway components for efficacy.

There are nuanced gene effects where certain knockouts boost particle production but diminish overall delivery potency, signaling a trade-off to optimize protein-cargo-limited settings.

Another set of genes boosted particle protein production but reduced delivery potency; in protein-cargo-limited contexts these could still enhance potency.

Collaborations aim to improve delivery to immune cells, neurons, and other cell types essential for treating various diseases.

A Whitehead Institute study proposes optimizing producer cells, not just the virus-like particles, to boost gene editing delivery efficiency and cargo loading.

The findings, published in Nature Communications, aim to enable more efficient, scalable, and safer delivery of gene-editing tools for treating genetic diseases.

Engineered producer cells improved particle production across various editors and delivery systems, suggesting broad applicability of this cellular engineering approach.

The improvement from this gene knockout was observed across different cargo types and delivery systems, indicating broad applicability.

Researchers conducted a genome-wide knockout screen in human producer cells to identify gene functions that promote or hinder VLP production, linking each knocked-out gene to the particle via a barcode system.